Document is current
Any future updates will be listed below
-
Authors
Oslund, Rob C. https://orcid.org/0000-0002-2920-9532
Reyes-Robles, Tamara https://orcid.org/0000-0001-7753-7971
White, Cory H.
Tomlinson, Jake H.
Crotty, Kelly A. https://orcid.org/0000-0001-8462-5275
Bowman, Edward P.
Chang, Dan
Peterson, Vanessa M.
Li, Lixia
Frutos, Silvia
Vila-Perelló, Miquel
Vlerick, David
Cromie, Karen
Perlman, David H.
Ingale, Sampat
Hara, Samantha D. O’
Roberts, Lee R.
Piizzi, Grazia
Hett, Erik C.
Hazuda, Daria J.
Fadeyi, Olugbeminiyi O. https://orcid.org/0000-0002-5525-1304
- License Information
-
More Information
Article History
Received: 29 January 2022
Accepted: 22 April 2022
First Online: 2 June 2022
Competing interests
: R.C.O., T.R.-R., C.H.W., J.H.T., K.A.C., D.H.P., S.I., S.D.O., L.R.R., G.P., L.L., D.C., V.M.P., E.P.B., E.C.H., D.J.H. and O.O.F. were employed by Merck & Co., S.F. and M.V.-P. were employed by SpliceBio and D.V. and K.C. were employed by Ablynx, Inc., during the experimental planning, execution and/or preparation of this manuscript. Merck & Co. has filed patents related to the technology and VHH sequences described herein listing R.C.O., T.R.-R. and O.O.F. as inventors (WO2020247725A1) and R.C.O., E.P.B. and O.O.F. as inventors (63/285,520).
